Y Antero Kesäniemi

Author PubWeight™ 116.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008 10.03
2 LDL-cholesterol concentrations: a genome-wide association study. Lancet 2008 6.44
3 Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2010 4.08
4 Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction. Circulation 2011 3.38
5 The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil 2005 2.78
6 Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring) 2009 2.07
7 Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003 1.82
8 Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene. Arterioscler Thromb Vasc Biol 2003 1.65
9 Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis. J Am Coll Cardiol 2008 1.64
10 The effect of correcting for troponins on trends in coronary heart disease events in Finland during 1993-2002: the FINAMI study. Eur Heart J 2006 1.63
11 Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 2003 1.63
12 Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis. Arterioscler Thromb Vasc Biol 2008 1.62
13 A blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32,669 individuals. Hypertension 2013 1.60
14 Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a). Arterioscler Thromb Vasc Biol 2004 1.58
15 ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease. Atherosclerosis 2003 1.58
16 Sequencing analysis of ghrelin gene 5' flanking region: relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index. Metabolism 2006 1.47
17 Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J Am Coll Cardiol 2002 1.46
18 Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s. Eur Heart J 2005 1.44
19 Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men. J Hypertens 2002 1.41
20 Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes. J Endocrinol Invest 2005 1.39
21 Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet 2011 1.38
22 Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study. Atherosclerosis 2007 1.36
23 Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol 2005 1.32
24 A new definition for myocardial infarction: what difference does it make? Eur Heart J 2005 1.32
25 Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation 2009 1.20
26 Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Eur Heart J 2009 1.17
27 APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res 2004 1.16
28 Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation 2002 1.11
29 A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2006 1.08
30 Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study. Ann Med 2005 1.04
31 Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia. J Lipid Res 2005 1.00
32 Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey. Atherosclerosis 2008 0.97
33 Tomato juice decreases LDL cholesterol levels and increases LDL resistance to oxidation. Br J Nutr 2007 0.96
34 Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohort. Diabetes Care 2012 0.95
35 Estrogen replacement therapy increases plasma ghrelin levels. J Clin Endocrinol Metab 2005 0.95
36 High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J Clin Endocrinol Metab 2006 0.94
37 Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs--apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes. Ann Med 2009 0.94
38 Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey. Atherosclerosis 2009 0.93
39 Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol 2006 0.93
40 R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events. Atherosclerosis 2004 0.93
41 Interactions between ghrelin, leptin and IGF-I affect metabolic syndrome and early atherosclerosis. Ann Med 2008 0.93
42 The signal sequence polymorphism of the MnSOD gene is associated with the degree of carotid atherosclerosis. Atherosclerosis 2003 0.90
43 Resistin is an indicator of the metabolic syndrome according to five different definitions in the Finnish Health 2000 survey. Metab Syndr Relat Disord 2011 0.90
44 Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study. Circulation 2011 0.90
45 A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies. Atherosclerosis 2003 0.89
46 Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial. Am J Cardiol 2010 0.89
47 Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding. Metabolism 2009 0.89
48 Glomerular filtration rate is related to carotid intima-media thickness in middle-aged adults. Nephrol Dial Transplant 2009 0.87
49 Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women. Metabolism 2008 0.87
50 Nondipping pattern and carotid atherosclerosis in a middle-aged population: OPERA Study. Am J Hypertens 2011 0.86
51 Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population. Metabolism 2008 0.86
52 Heart rate variability findings as a predictor of atrial fibrillation in middle-aged population. J Cardiovasc Electrophysiol 2014 0.85
53 Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors. Regul Pept 2008 0.85
54 The expression of human resistin in different leucocyte lineages is modulated by LPS and TNFalpha. Regul Pept 2009 0.85
55 Carotid artery intima-media thickness and elasticity in relation to glucose tolerance. Acta Diabetol 2011 0.84
56 Home-measured blood pressure is more strongly associated with atherosclerosis than clinic blood pressure: the Finn-HOME Study. J Hypertens 2007 0.84
57 Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia. J Clin Endocrinol Metab 2007 0.83
58 Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects. Metabolism 2007 0.83
59 Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes. Ann Med 2013 0.82
60 Leptin receptor Arg109 homozygotes display decreased total mortality as well as lower incidence of cardiovascular disease and related death. Gene 2013 0.82
61 High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism. J Clin Endocrinol Metab 2010 0.82
62 Ghrelin vaccination decreases plasma MCP-1 level in LDLR(-/-)-mice. Peptides 2009 0.82
63 Plasma adiponectin levels are associated with left ventricular hypertrophy in a random sample of middle-aged subjects. Ann Med 2010 0.82
64 Effects of estrogen replacement therapy on natriuretic peptides and blood pressure. Maturitas 2004 0.82
65 Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women. J Nutr 2002 0.81
66 Plasma adiponectin--an independent indicator of liver fat accumulation. Metabolism 2011 0.81
67 Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk. Atherosclerosis 2012 0.81
68 Aging of the population may not lead to an increase in the numbers of acute coronary events: a community surveillance study and modelled forecast of the future. Heart 2013 0.81
69 Two variants in the resistin gene and the response to long-term overfeeding. Eur J Clin Nutr 2004 0.81
70 Are coronary event rates declining slower in women than in men - evidence from two population-based myocardial infarction registers in Finland? BMC Cardiovasc Disord 2007 0.80
71 Non-dipping pattern in ambulatory blood pressure monitoring is associated with metabolic abnormalities in a random sample of middle-aged subjects. Hypertens Res 2009 0.80
72 Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation. Antioxid Redox Signal 2013 0.80
73 Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis. J Clin Endocrinol Metab 2009 0.80
74 Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population. J Neurogenet 2006 0.80
75 A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis. Heart 2011 0.80
76 Plasma lipid levels and body weight altered by intrauterine growth restriction and postnatal fructose diet in adult rats. Pediatr Res 2012 0.79
77 Leptin receptor Lys109Arg and Gln223Arg polymorphisms are associated with early atherosclerosis. Metab Syndr Relat Disord 2010 0.79
78 High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults. J Hypertens 2012 0.79
79 Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. BMJ Open 2014 0.79
80 Increased daily sodium intake is an independent dietary indicator of the metabolic syndrome in middle-aged subjects. Ann Med 2011 0.79
81 Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events. Atherosclerosis 2013 0.79
82 Sequencing analysis of the ghrelin receptor (growth hormone secretagogue receptor type 1a) gene. Eur J Endocrinol 2004 0.79
83 Variation in the vascular endothelial growth factor gene, carotid intima-media thickness and the risk of acute myocardial infarction. Scand J Clin Lab Invest 2009 0.79
84 Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study). Am J Cardiol 2010 0.79
85 Coronary events in persons aged 75 years or older in Finland from 1995 to 2002: the FINAMI study. Am J Geriatr Cardiol 2008 0.78
86 Adiponectin concentration in plasma is associated with muscle fiber size in healthy middle-aged men. Scand J Clin Lab Invest 2012 0.78
87 Plasma homocysteine concentration is decreased by dietary intervention. Br J Nutr 2003 0.78
88 Functional significance of KCNH2 (HERG) K897T polymorphism for cardiac repolarization assessed by analysis of T-wave morphology. Ann Noninvasive Electrocardiol 2006 0.78
89 Paraoxonase-1 gene Leu-Met55 and Gln-Arg192 polymorphisms are not associated with carotid artery atherosclerosis in a population-based cohort. Eur J Cardiovasc Prev Rehabil 2004 0.78
90 Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis. Atherosclerosis 2004 0.77
91 Fasting plasma total ghrelin concentrations in monozygotic twins discordant for obesity. Metabolism 2009 0.77
92 The effect of energy restriction during pregnancy on obesity-related peptide hormones in rat offspring. Peptides 2008 0.77
93 Long telomeres in blood leukocytes are associated with a high risk of ascending aortic aneurysm. PLoS One 2012 0.76
94 Comparison of family history of sudden cardiac death in nonischemic and ischemic heart disease. Circ Arrhythm Electrophysiol 2012 0.76
95 Low-density lipoprotein clearance in patients with chronic renal failure. Nephrol Dial Transplant 2009 0.76
96 Long-term fructose feeding changes the expression of leptin receptors and autophagy genes in the adipose tissue and liver of male rats: a possible link to elevated triglycerides. Genes Nutr 2013 0.75
97 Gene expression profiles in fetal and neonatal rat offspring of energy-restricted dams. J Nutrigenet Nutrigenomics 2010 0.75
98 Peptide hormones in infants with feeding disorders. Scand J Clin Lab Invest 2013 0.75
99 Association between angiotensin-converting enzyme insertion/deletion polymorphism and treatment response in type 2 diabetic patients. Eur J Intern Med 2006 0.75
100 Temporal changes in cardiovascular autonomic regulation in type II diabetic patients: association with coronary risk variables and progression of coronary artery disease. Ann Med 2003 0.75
101 [Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary]. Clin Investig Arterioscler 2013 0.75